TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T20331	Neuropeptide Y receptor type 5	B0JAI2	2-Diphenylacetylamino-5-guanidino-pentanoic acid [1-(4-hydroxy-phenyl)-ethyl]-amide	Investigative	44288112	C28H33N5O3	487.6	CC(C1=CC=C(C=C1)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3	IC50 = 75000 nM	Poor binder
T20331	Neuropeptide Y receptor type 5	B35VLW	2-Diphenylacetylamino-5-guanidino-pentanoic acid ((S)-2-hydroxy-1-phenyl-ethyl)-amide	Investigative	44287971	C28H33N5O3	487.6	C1=CC=C(C=C1)[C@@H](CO)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3	IC50 = 68000 nM	Poor binder
T20331	Neuropeptide Y receptor type 5	B75MXH	2-Diphenylacetylamino-5-guanidino-pentanoic acid 4-hydroxy-benzylamide	Investigative	21129772	C27H31N5O3	473.6	C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NCC3=CC=C(C=C3)O	IC50 = 80000 nM	Poor binder
T20331	Neuropeptide Y receptor type 5	B9BLS5	2-Diphenylacetylamino-5-guanidino-pentanoic acid ((R)-carbamoyl-phenyl-methyl)-amide	Investigative	44287982	C28H32N6O3	500.6	C1=CC=C(C=C1)[C@H](C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3	IC50 = 163000 nM	Poor binder
T20331	Neuropeptide Y receptor type 5	BG83PQ	N-[4beta-[(2-Naphthylsulfonylamino)methyl]cyclohexane-1alpha-ylmethyl]-2-tetralincarboxamide	Investigative	44295140	C29H34N2O3S	490.7	C1CC(CCC1CNC(=O)C2CCC3=CC=CC=C3C2)CNS(=O)(=O)C4=CC5=CC=CC=C5C=C4	Ki ~ 100000 nM	Poor binder